Should I Buy CTS? CTS 2026 Analysis

Should You Buy CTS Corp (CTS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

53.280

1 Day change

0.30%

52 Week Range

54.230

Analysis Updated At

2026/01/28

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for a beginner long-term investor who wants to act immediately. CTS is in a bullish technical uptrend, but momentum is cooling (MACD contracting), hedge funds have been aggressively selling, and the nearest catalyst is the upcoming earnings release (Feb 10, 2026) with recent YoY profit/EPS declines. If you must deploy capital now, this setup is better treated as a watch/hold rather than a fresh long-term entry at ~$50.44.

Technical Analysis

Trend is still bullish: SMA_5 > SMA_20 > SMA_200 indicates a sustained uptrend. Momentum: MACD histogram is positive (0.308) but contracting, suggesting upside momentum is fading rather than accelerating. RSI(6)=64.7 is neutral-to-warm (not oversold), so there’s no obvious ‘discount’ entry. Key levels: pivot/support ~49.14 (then 47.04), resistance ~51.23 (then 52.53). With price around 50.44 and close to R1, near-term upside looks more limited versus downside back to support. Pattern-based projection also skews negative over 1 week to 1 month (-1.32% to -8.59%), reinforcing that this is not an ideal chase level.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options positioning is mildly bullish/constructive on open interest (put/call OI=0.5), but actual trading activity is essentially absent (today volume=0; call volume=0; put volume=0). Implied volatility is elevated (30D IV ~49%) versus historical volatility (~39%), implying the market is pricing meaningful uncertainty into the near-term (consistent with the upcoming earnings event).

Net: sentiment from OI leans positive, but low volume makes it a weak signal.

Technical Summary

Sell

Buy

Positive Catalysts

and gross margin improved (38.71%, +4.17% YoY), which can support longer-term quality/operating leverage narratives if profitability stabilizes.

Neutral/Negative Catalysts

shows profit pressure: net income down -24.31% YoY and EPS down -22.03% YoY despite higher revenue—this can cap near-term multiple expansion. Technical momentum is weakening (MACD contracting) and price is nearer resistance than support. No recent insider buying signal (insiders neutral). No recent congress trading data available (no supportive political-flow signal).

Financial Performance

Latest reported quarter: 2025/Q3. Revenue grew to ~$142.97M (+8.00% YoY), and gross margin rose to 38.71% (+4.17% YoY), showing healthy top-line demand and better gross profitability. However, net income fell to ~$13.69M (-24.31% YoY) and EPS fell to $0.46 (-22.03% YoY), indicating operating costs/other items are weighing on bottom-line growth. Overall: mixed—good revenue/margin trend, but earnings trend is currently negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating trend or price-target change data was provided, so Wall Street pros/cons cannot be confirmed from the dataset. Based on available fundamentals alone, the ‘pro’ case is steady revenue growth and improved gross margin; the ‘con’ case is declining EPS/net income and bearish institutional flow (hedge-fund selling).

Analyst Rating

Wall Street analysts forecast CTS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy